Mouse Mttp/1810043K16Rik/MT ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_001163457.2)

Cat. No.: pGMAAV000715
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Mttp/1810043K16Rik/MT Adeno-associated virus expression plasmid (ITR-vector) for Mttp AAV packaging, Mttp AAV production.The purified Mouse Mttp/1810043K16Rik/MT AAV particle serves as an invaluable asset for in-depth in vivo Mttp studies, mechanism of action (MOA) research, and the evolution of Mttp-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV000715
Gene Name Mttp
Accession Number NM_001163457.2
Gene ID 17777
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 2730 bp
Gene Alias 1810043K16Rik,MT,MTP
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGACAGTCGTGATGGGGAAATGTCAAGTATCAGATGGACGCCAGCTTTTGTTATTTTATGCCGTGCTGTTACTCTTTCCTACTTTGTGTGCCATGCAAAATAGCGGTCACACAACTGGCCTCTCATTAAATAATGAGCGGCTATACAAGCTCACGTACTCCACTGAAGTGTTTCTTGATGGGGGCAAAGGAAAACCGCAAGACAGCGTGGGCTACAAAATCTCATCTGATGTGGACGTTGTGTTACTGTGGAGGAATCCTGATGGTGATGATGATCAAGTGATCCAAGTCACGATAACAGCTGTTAACGTTGAAAATGCGGGTCAACAGAGAGGCGAGAAGAGCATCTTCCAGGGCAAAAGTACACCTAAGATCATAGGGAAGGACAACCTGGAGGCTCTGCAGAGACCCATGCTTCTTCATCTGGTCCGGGGGAAGGTCAAGGAGTTCTACTCCTATGAAAACGAGCCAGTGGGCATAGAAAATCTCAAGAGAGGCTTGGCTAGCTTATTCCAGATGCAGCTAAGCTCTGGAACTACCAACGAGGTAGATATCTCTGGGGATTGTAAAGTGACCTACCAGGCCCAGCAAGACAAAGTGGTCAAAATTAAGGCTCTGGATACATGCAAAATTGAGCGGTCTGGATTTACAACGGCAAACCAGGTGCTGGGTGTCAGTTCAAAAGCCACATCTGTCACTACCTACAAGATAGAGGACAGCTTTGTCACCGCTGTGCTTGCAGAAGAGACCAGGGCTTTTGCCTTGAACTTCCAACAAACCATAGCAGGAAAAATAGTGTCGAAGCAGAAATTGGAGCTGAAGACAACTGAAGCCGGCCCAAGGATGATCCCCGGGAAGCAAGTGGCAGGTGTAATTAAAGCAGTTGATTCCAAATACAAAGCCATTCCCATTGTGGGACAGGTCCTCGAGCGTGTCTGCAAAGGATGCCCTTCTCTGGCGGAGCACTGGAAGTCCATCAGAAAGAACCTGGAGCCTGAAAACCTGTCCAAGGCCGAGGCCGTCCAGAGCTTCCTGGCCTTCATTCAGCACCTCCGGACTTCGAGGAGAGAAGAGATCCTCCAGATTCTGAAGGCAGAGAAGAAAGAAGTGCTCCCTCAGCTGGTGGATGCCGTCACCTCTGCTCAGACTCCAGACTCGCTAGAAGCCATCCTGGACTTTTTGGATTTCAAAAGTGACAGCAGTATCATACTCCAGGAAAGGTTCCTCTATGCCTGTGGCTTTGCCACCCACCCTGATGAAGAACTCCTACGAGCCCTCCTTAGTAAGTTCAAAGGTTCCTTTGCAAGCAACGACATCAGAGAGTCGGTTATGATCATCATTGGAGCCCTGGTCAGGAAGCTGTGTCAGAATGAAGGCTGCAAGCTCAAGGCAGTGGTGGAAGCTAAGAAGCTGATCCTGGGAGGACTTGAAAAACCAGAGAAGAAAGAAGACACCACAATGTACCTGCTGGCCCTGAAGAATGCCTTGCTTCCCGAAGGCATCCCGCTCCTTCTGAAGTATGCTGAGGCTGGAGAAGGGCCCGTCAGCCACCTGGCCACCACTGTTCTCCAGAGATACGATGTCTCCTTCATCACAGATGAGGTGAAGAAGACCTTGAACAGGATATACCACCAGAATCGTAAGGTTCATGAGAAGACGGTGCGCACAACTGCCGCTGCTGTCATCTTAAAGAACCCATCCTACATGGATGTGAAGAACATCCTGCTGTCCATTGGGGAACTCCCGAAAGAGATGAACAAATACATGCTCACTGTTGTGCAAGACATCCTGCATTTTGAAATGCCTGCAAGCAAAATGATCCGTCGAGTTCTCAAGGAGATGGCTGTTCACAATTATGACCGTTTCTCCAAGAGTGGATCCTCTTCTGCCTATACTGGCTACGTAGAACGTAGCCCCCGTGCAGCGTCCACATACAGCCTTGACATCCTTTACTCTGGCTCTGGCATTCTGAGGAGAAGTAACCTGAACATCTTCCAGTACATCGGGAAGGCAGAGCTTCATGGTAGTCAGGTGGTGATTGAAGCCCAAGGGCTGGAAGGCTTAATTGCAGCCACTCCTGATGAAGGAGAGGAGAACCTTGACTCTTATGCTGGCATGTCAGCCATCCTGTTTGATGTTCAGCTTAGGCCTGTCACATTTTTTAATGGATACAGTGATTTGATGTCCAAAATGCTGTCGGCATCCGGCGACCCTGTCAGCGTGGTGAAAGGGCTTATTCTGTTAATAGACCATTCTCAGGATATTCAGCTGCAATCTGGACTAAAGGCCAATATGGAGATCCAGGGTGGTCTAGCTATTGATATTTCTGGTTCAATGGAATTCAGTCTGTGGTATCGAGAGTCTAAAACCCGAGTGAAAAATCGGGTGGCTGTGGTGATAACCAGCGACGTCACAGTGGATGCCTCTTTTGTGAAAGCTGGTGTGGAAAGCAGAGCGGAGACAGAGGCTGGGCTGGAGTTCATCTCCACAGTGCAGTTCTCACAGTACCCGTTCTTGGTCTGCATGCAGATGGACAAGGCTGAAGCCCCACTCAGGCAATTCGAGACAAAGTATGAAAGGCTATCTACAGGCAGGGGATATGTCTCTCGGAGAAGAAAAGAGAGCCTAGTGGCCGGATGTGAACTCCCCCTCCATCAAGAGAACTCTGAGATGTGCAACGTGGTATTCCCACCTCAGCCAGAAAGCGATAACTCCGGTGGATGGTTTTGA
ORF Protein Sequence MTVVMGKCQVSDGRQLLLFYAVLLLFPTLCAMQNSGHTTGLSLNNERLYKLTYSTEVFLDGGKGKPQDSVGYKISSDVDVVLLWRNPDGDDDQVIQVTITAVNVENAGQQRGEKSIFQGKSTPKIIGKDNLEALQRPMLLHLVRGKVKEFYSYENEPVGIENLKRGLASLFQMQLSSGTTNEVDISGDCKVTYQAQQDKVVKIKALDTCKIERSGFTTANQVLGVSSKATSVTTYKIEDSFVTAVLAEETRAFALNFQQTIAGKIVSKQKLELKTTEAGPRMIPGKQVAGVIKAVDSKYKAIPIVGQVLERVCKGCPSLAEHWKSIRKNLEPENLSKAEAVQSFLAFIQHLRTSRREEILQILKAEKKEVLPQLVDAVTSAQTPDSLEAILDFLDFKSDSSIILQERFLYACGFATHPDEELLRALLSKFKGSFASNDIRESVMIIIGALVRKLCQNEGCKLKAVVEAKKLILGGLEKPEKKEDTTMYLLALKNALLPEGIPLLLKYAEAGEGPVSHLATTVLQRYDVSFITDEVKKTLNRIYHQNRKVHEKTVRTTAAAVILKNPSYMDVKNILLSIGELPKEMNKYMLTVVQDILHFEMPASKMIRRVLKEMAVHNYDRFSKSGSSSAYTGYVERSPRAASTYSLDILYSGSGILRRSNLNIFQYIGKAELHGSQVVIEAQGLEGLIAATPDEGEENLDSYAGMSAILFDVQLRPVTFFNGYSDLMSKMLSASGDPVSVVKGLILLIDHSQDIQLQSGLKANMEIQGGLAIDISGSMEFSLWYRESKTRVKNRVAVVITSDVTVDASFVKAGVESRAETEAGLEFISTVQFSQYPFLVCMQMDKAEAPLRQFETKYERLSTGRGYVSRRRKESLVAGCELPLHQENSEMCNVVFPPQPESDNSGGWF

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV000715 Mouse Mttp Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.